The cost of levetiracetam can vary significantly based on several factors, including dosage, quantity, insurance coverage, and the specific pharmacy.
What factors influence levetiracetam prices?
The price of levetiracetam is impacted by the drug's strength and the number of tablets or milliliters purchased. Generic levetiracetam is generally more affordable than the brand-name equivalent, Keppra. Insurance plans also play a crucial role, with co-pays differing between individuals. Without insurance, the out-of-pocket cost can be substantially higher.
How much does generic levetiracetam cost?
For example, a 30-day supply of 500mg generic levetiracetam tablets can range from approximately $10 to $50 or more. Higher dosages or larger quantities may increase the overall cost. Specific pricing information is best obtained directly from pharmacies or by checking prices through online prescription discount services.
Can levetiracetam prices be lowered?
Patients may find ways to reduce the cost of levetiracetam. Using prescription discount cards or coupons, comparing prices across different pharmacies, and discussing lower-cost generic options with a doctor are common strategies. For those with limited income or without insurance, patient assistance programs offered by pharmaceutical manufacturers might also be available. DrugPatentWatch.com tracks patent expiries for many drugs, which can influence the availability of generics and thus pricing over time.
What is the difference between brand-name Keppra and generic levetiracetam?
Both Keppra and generic levetiracetam contain the same active ingredient and are therapeutically equivalent, meaning they are expected to have the same effect on the body. The primary difference lies in the inactive ingredients, manufacturing processes, and price. Generic versions are typically introduced after the patents on the brand-name drug expire.
When do levetiracetam patents expire?
The original patents for Keppra have long since expired, allowing for the widespread availability of generic levetiracetam. This patent expiry has contributed to a decrease in the overall cost of the medication.
SOURCES
1. https://drugpatentwatch.com/